Cerenome (CNSY) Reports Q3 Results, CNSide Revenue and Clinical Progress

Cerenome reported Q3 2026 financial results and business updates, including its first quarter of CNSide diagnostic revenue. It also said payer coverage reaches about 80% of U.S. private payers, representing approximately 190M covered lives.Material DetailsContext by AI AnalystThis is an early comme…